Ubiquinol
Best-in-class: Ubiquinol
The reduced, already-active form of CoQ10. Whether paying three times as much for it is worth anything is a more open question than the marketing suggests.
Ubiquinol quick facts
| Suggested dose | 100–200 mg daily with fat. |
| How often | daily |
| Who it's for | Possibly worth it over 60 or on a statin, where absorption of the oxidized form may be less efficient. Otherwise, oil-based ubiquinone is fine. |
Worth the premium over ubiquinone mainly in older adults and in heart failure, where conversion capacity is measurably reduced — in a healthy younger person the body converts either form fine and the cheaper one is sensible. Statins inhibit the same pathway that makes CoQ10, which is the mechanistic basis for co-supplementing. Absorption requires fat regardless of form.
How Ubiquinol actually works
The reduced, electron-carrying form of CoQ10. In the mitochondrial inner membrane CoQ shuttles electrons between complexes I/II and III, and it cycles between ubiquinone and ubiquinol as it does so. Ubiquinol is also the form that acts as a lipid-phase antioxidant, regenerating vitamin E. Supplementing the reduced form skips the conversion step, which becomes less efficient with age.
Where to get Ubiquinol
Buy Ubiquinol at Thorne →The evidence for Ubiquinol
Graded by what exists behind each claim.
✅ Clinically validated
- Bioavailability trials generally show higher plasma CoQ10 from ubiquinol than from equivalent ubiquinone, though several head-to-head studies find no meaningful difference once the ubiquinone is oil-solubilized.
- Crucially, the major clinical outcome trial in heart failure (Q-SYMBIO) used UBIQUINONE, not ubiquinol, and showed reduced cardiovascular mortality. The outcome data sits with the cheaper form.
📊 Correlative data
- Circulating CoQ10 falls with age and is measurably lower in heart failure populations, which is the observational basis. The conversion argument — that older adults reduce ubiquinone to ubiquinol less efficiently — is mechanistic rather than demonstrated in outcome data.
🧪 Theoretical / extrapolated benefits
- The body interconverts the two forms continuously via redox cycling, which undercuts the 'you need the active form' argument.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Ubiquinol actually does
Ubiquinol and ubiquinone are the same molecule two electrons apart, and the body interconverts them constantly -- which is why the premium form argument is weaker than it looks. Coenzyme Q10 is a benzoquinone with a 50-carbon isoprenoid tail; that tail is what anchors it in the inner mitochondrial membrane, and the quinone head is what accepts and donates electrons between complexes I and II and complex III. Accepting two electrons makes it ubiquinol; donating them makes it ubiquinone again, thousands of times a second.
The reduction is also performed outside the mitochondrion. NAD(P)H quinone dehydrogenase 1 and other reductases reduce ubiquinone in plasma membranes and lipoproteins, which is why more than 90 percent of circulating coenzyme Q10 is in the reduced form regardless of which form was swallowed. Buying the reduced form buys an absorption argument, not a redox-state argument.
The measurement itself has a redox clock, and this is the detail that undermines a lot of comparison marketing. The ratio of the two forms in a drawn sample shifts with handling, storage and time before analysis, which is why analytical work on coenzyme Q10 quantification has to validate the method rather than assume it Paredes-Fuentes 2022. A bioavailability comparison is only as good as its sample handling.
The statin connection is a synthesis clock. HMG-CoA reductase makes mevalonate, which is the precursor of both cholesterol and the isoprenoid tail, so inhibiting it lowers endogenous coenzyme Q10 synthesis. Statin therapy has been shown to reduce plasma coenzyme Q10 concentrations alongside other lipophilic species Motkowski 2022. Whether that depletion causes the muscle symptoms is the separate question the trials below were built to answer.
Cell, rodent, human — and where it stops
The outcome data and the absorption data point at different products, and that is the most useful thing on this page.
What has been measured in people. The major clinical outcome trial in chronic heart failure used ubiquinone and reported reduced cardiovascular mortality Mortensen 2014. A head-to-head study compared coenzyme Q10 as ubiquinone against reduced coenzyme Q10 as ubiquinol as supplements Fladerer 2023. In statin-treated patients, a double-blinded randomized placebo-controlled trial measured the effect of supplementation Dohlmann 2022, and two meta-analyses pooled the myopathy question Wei 2022 Kovacic 2025.
The first obstacle is that the strongest outcome evidence belongs to the cheaper form. The mortality trial used ubiquinone Mortensen 2014. Every marketing claim that ubiquinol is the clinically proven form is transferring a result across a product boundary the trial did not cross.
The second obstacle is that plasma coenzyme Q10 is not muscle coenzyme Q10. Supplementation reliably raises the plasma concentration; whether it raises the intramuscular concentration, which is where statin-associated myalgia would have to be addressed, is the step the trials do not close Dohlmann 2022.
The third obstacle is heterogeneity in the myopathy meta-analyses. Two pooled analyses of statin-associated muscle symptoms reach cautious conclusions from a literature of small trials with varied definitions of myopathy Wei 2022 Kovacic 2025, and the unresolved issues in coenzyme Q10 metabolism have been reviewed specifically because they complicate every one of these comparisons Mantle 2023.
What would close the gap. Report muscle coenzyme Q10 by biopsy or a validated proxy alongside the symptom score, with sample handling specified so the redox ratio means something Paredes-Fuentes 2022.
Ubiquinol — which form, and does it matter
The form premium is real, bounded, and mostly closed by a meal. Ubiquinol is more polar than ubiquinone and disperses more readily, which is the basis for its absorption advantage. Head-to-head work comparing the two as supplements is what defines the size of that advantage rather than the marketing Fladerer 2023.
Solubilization matters at least as much as oxidation state. An oil-solubilized ubiquinone softgel taken with a fatty meal behaves very differently from a dry ubiquinone powder in a hard capsule taken with water, and the comparison that produces the largest apparent ubiquinol advantage is usually against the latter Mantle 2023.
The age argument is the one legitimate use of the premium. The capacity to reduce ubiquinone declines with age and with some disease states, which is a mechanistic reason the reduced form might matter more later in life. It is a reason to consider it, not a demonstrated outcome advantage Mantle 2023.
Ubiquinol is also the less stable molecule. It oxidizes on exposure to air and light, which is why it is packaged in nitrogen-flushed softgels; the same instability is what makes sample handling decisive in the analytical literature Paredes-Fuentes 2022. No filed panel for the vendor ubiquinol product on this site has been read into supplements_data.BLENDS.
What would have to be true, and how you would know it was not
1. The plasma prediction, at 4 weeks. Plasma coenzyme Q10 at baseline and 4 weeks at 100 to 200 mg with a fatty meal. Predict a several-fold rise on either form, and predict that oil-solubilized ubiquinone with food closes most of the gap to ubiquinol Fladerer 2023.
2. The handling prediction, which is a laboratory instruction. Predict that the measured ubiquinol-to-ubiquinone ratio depends on how long the sample sat and how it was stored, which is why the analytical method has to be validated rather than assumed Paredes-Fuentes 2022.
3. The statin prediction, deliberately unflattering. In someone with statin-associated muscle symptoms, predict a modest and unreliable symptom change at 12 weeks, because that is what the pooled analyses describe Wei 2022 Kovacic 2025 Dohlmann 2022. Predict also that plasma coenzyme Q10 rises regardless, which is why the plasma number is a poor guide to whether it helped.
4. The blood pressure prediction. Home blood pressure averaged over a week at baseline and 12 weeks. Predict a small reduction at most, and predict it is additive with antihypertensive medication rather than independent of it.
5. The form falsification. Same person, oil-solubilized ubiquinone with food for 4 weeks and ubiquinol with food for 4 weeks, same plasma assay with identical handling. Prediction: a difference smaller than the price difference Fladerer 2023. A large difference would justify the premium and this section would be wrong.
What nobody has tested yet
Nobody has repeated the heart failure mortality trial with the reduced form. The outcome evidence sits with ubiquinone Mortensen 2014 and the premium sits with ubiquinol, and no trial has crossed that gap.
Nobody has shown supplementation raises muscle coenzyme Q10. Plasma rises reliably; the intramuscular question is the unresolved one and it is central to the myopathy claim Mantle 2023 Dohlmann 2022.
Nobody has stratified by statin-induced depletion. Statins lower plasma coenzyme Q10 Motkowski 2022, and no trial has enrolled only the people in whom it actually fell.
And nobody has agreed on a reference range. The unresolved issues in coenzyme Q10 metabolism include what a deficient plasma concentration even is Mantle 2023 Paredes-Fuentes 2022.
Ubiquinol — its own safety story, not its category's
This is one of the better-tolerated compounds in the catalog, and its most consequential interaction is with warfarin. Coenzyme Q10 is structurally similar to vitamin K and can reduce the anticoagulant effect, which matters more with a better-absorbed form. Anyone on warfarin needs the prescriber to know before the first capsule, and consistency of intake thereafter.
It lowers blood pressure modestly, which is additive. That is usually a benefit and occasionally a reason for dizziness in somebody already treated. Home blood pressure monitoring for the first few weeks is the sensible response.
The one thing it should not be used to do is override a prescriber's decision about a statin. The pooled evidence on statin-associated muscle symptoms is modest and inconsistent Wei 2022 Kovacic 2025 Dohlmann 2022. Persistent muscle pain on a statin is a conversation about the statin, not a reason to add a supplement and keep going.
The honest budget note. The form with the mortality trial behind it is the cheaper one Mortensen 2014, and taking oil-solubilized ubiquinone with a fatty meal closes most of the absorption gap Fladerer 2023 Mantle 2023. Mild nausea and insomnia at higher doses are the usual complaints. Nothing here is medical advice or a diagnosis, and none of these statements has been evaluated by the Food and Drug Administration.
Sources read for this page
- Fladerer JP, et al. Comparison of Coenzyme Q10 (Ubiquinone) and Reduced Coenzyme Q10 (Ubiquinol) as Supplement to Prevent Cardiovascular Disease and Reduce Cardiovascular Mortality. Current Cardiology Reports 2023 · PMID 37971634
- Mantle D, et al. Coenzyme Q10 Metabolism: A Review of Unresolved Issues. International Journal of Molecular Sciences 2023 · PMID 36768907
- Paredes-Fuentes AJ. Technical Aspects of Coenzyme Q10 Analysis: Validation of a New HPLC-ED Method. Antioxidants (Basel) 2022 · PMID 35326178
- Motkowski R. Effect of Statin Therapy on the Plasma Concentrations of Retinol, Alpha-Tocopherol and Coenzyme Q10 in Children with Familial Hypercholesterolemia. Cardiovasc Drugs Ther 2022 · PMID 33052507
- Wei H, et al. Effects of coenzyme Q10 supplementation on statin-induced myopathy: a meta-analysis of randomized controlled trials. Irish Journal of Medical Science 2022 · PMID 33999383
- Kovacic S. Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis. J Nutr Sci 2025 · PMID 41158831
- Dohlmann TL. Coenzyme Q10 Supplementation in Statin Treated Patients: A Double-Blinded Randomized Placebo-Controlled Trial. Antioxidants (Basel) 2022 · PMID 36139772
- Mortensen SA, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO, a randomized double-blind trial. JACC: Heart Failure 2014 · PMID 25282031
How you would know if it worked
This is the rare supplement argument you can settle personally, because plasma CoQ10 is on the menu. Measure it on oil-solubilized ubiquinone taken with a meal, switch to ubiquinol at the same dose for twelve weeks, and measure again — if the number does not move, you have answered the only question the price premium rests on, for yourself, which is the only person it matters for. Read it against a lipid panel drawn the same morning, because CoQ10 travels on lipoproteins: a level that rose while LDL rose has not necessarily told you more of it reached your cells.
- Coenzyme Q10 — Ubiquinol 100–200 mg/day with a fat-containing meal (better absorbed than ubiquinone, especially over 40) Retest: 12 weeks after starting supplementation.
- Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) Retest: Every 3–6 months on androgens; annually otherwise.
The cheapest panel carrying Coenzyme Q10 and at least one other of these is On a Statin — What It Moves and What It Misses, at $178 — the panel is named for a different question, and the marker is the same marker. That is the whole cost of finding out.
Draw before you start, not after. A result with nothing to compare it to answers nothing.
Ubiquinol — safety & side effects
- Same profile as CoQ10 — the reduced, better-absorbed form.
- Same warfarin interaction, and arguably more relevant given the better absorption.
- Lowers blood pressure modestly. The absorption advantage matters most over age 40, when conversion of ubiquinone to ubiquinol declines.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Ubiquinol in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Ubiquinol
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| hs-CRP (High-Sensitivity C-Reactive Protein) | The inflammation these are aimed at |
| ApoB (Apolipoprotein B) | Cardiovascular risk, measured properly |
| HbA1c (Hemoglobin A1c) | Glycation over three months |
| Comprehensive Metabolic Panel (CMP) | Liver and kidney baseline |
The Longevity Baseline panel covers these in one order — 13 markers, $219.10 with the discount applied.
Check results you already have → · All 103 markers A–Z
Ubiquinol — frequently asked questions
What is Ubiquinol?
The reduced, already-active form of CoQ10. Whether paying three times as much for it is worth anything is a more open question than the marketing suggests.
What is the suggested dose of Ubiquinol?
100–200 mg daily with fat. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Ubiquinol dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Ubiquinol?
Coach Cam sources Ubiquinol from Thorne, with 10% off auto-applied at checkout — use the buy link on this page.
Ubiquinol inside a finished plan
One arm of 3 Protocol Blueprints, free to read in full.
What Ubiquinol is used for
Ubiquinol appears under 4 goals in the goal router.
Related Longevity & Antioxidants supplements
Where this goes next
Ubiquinol is the autophagy arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.